Adverse drug reactions in Germany: direct costs of internal medicine hospitalizations. - Wikidata - awgldk - TriplyDB

Adverse drug reactions in Germany: direct costs of internal medicine hospitalizations.

Adverse drug reactions in Germany: direct costs of internal medicine hospitalizations.

http://www.wikidata.org/entity/Q45093086

about

Simulated presence therapy for dementia Cost-Effectiveness of Pharmacogenomic and Pharmacogenetic Test-Guided Personalized Therapies: A Systematic Review of the Approved Active Substances for Personalized Medicine in Germany A systematic review of observational studies evaluating costs of adverse drug reactions Medication monitoring in a nurse-led respiratory outpatient clinic: pragmatic randomised trial of the West Wales Adverse Drug Reaction Profile Dictionary construction and identification of possible adverse drug events in Danish clinical narrative text Dose-Specific Adverse Drug Reaction Identification in Electronic Patient Records: Temporal Data Mining in an Inpatient Psychiatric Population Simulated presence therapy for dementia.Adverse drug reactions to anticoagulants in Spain: analysis of the Spanish National Hospital Discharge Data (2010-2013).Multifaceted interventions for improving spontaneous reporting of adverse drug reactions in a general hospital in China.Instantaneous detection of nonadherence: quality, strength, and weakness of an electronic prescription database.Seriousness, preventability, and burden impact of reported adverse drug reactions in Lombardy emergency departments: a retrospective 2-year characterization.Personalizing health care: feasibility and future implications.Medication management for people with dementia in primary care: description of implementation in the DelpHi study.Evidence of and recommendations for non-pharmacological interventions for common geriatric conditions: the SENATOR-ONTOP systematic review protocol.A cost-effectiveness analysis of an in-hospital clinical pharmacist service.Reducing Polypharmacy from the Perspectives of General Practitioners and Older Patients: A Synthesis of Qualitative Studies.Simulated presence therapy for dementia: a systematic review protocol Prospective Observational Study of Adverse Drug Reactions of Anticancer Drugs Used in Cancer Treatment in a Tertiary Care Hospital Bleeding complications and liver injuries during phenprocoumon treatment: a multicentre prospective observational study in internal medicine departments Potentially high-risk medication categories and unplanned hospitalizations: a case-time-control study.Pharmacovigilance systems in developing countries: an evaluative case study in Burkina Faso.Factors that condition the spontaneous reporting of adverse drug reactions among nurses: an integrative review.Development of a decision support system for the practice of responsible self-medication.Structured Pharmacist Review of Medication in Older Hospitalised Patients: A Cost-Effectiveness Analysis.Potential drug-drug interactions in paediatric outpatient prescriptions in Nigeria and implications for the future.Adverse-Drug-Reaction-Related Hospitalisations in Developed and Developing Countries: A Review of Prevalence and Contributing Factors.Hospitalizations due to preventable adverse reactions-a systematic review.A literature-based economic evaluation of healthcare preventable adverse events in Europe.[Pharmacovigilance in Germany : It is about time].Irrational Use of Medicines-A Summary of Key Concepts.The SENATOR project: developing and trialling a novel software engine to optimize medications and nonpharmacological therapy in older people with multimorbidity and polypharmacy Cost Evaluation of Irinotecan-Related Toxicities Associated With the UGT1A1*28 Patient Genotype.Direct health care costs of hospital admissions due to adverse events in The Netherlands.A survey of spontaneous reporting of adverse drug reactions in 10 years of activity in a pharmacovigilance centre in Portugal.Prevalence, risk factors and main features of adverse drug reactions leading to hospital admission.Adverse drug events in patients admitted to an emergency department: an analysis of direct costs.Self-medication with over-the-counter and prescribed drugs causing adverse-drug-reaction-related hospital admissions: results of a prospective, long-term multi-centre study.Evaluation of drug-drug interaction screening software combined with pharmacist intervention.Drug-induced blood consumption: the impact of adverse drug reactions on demand for blood components in German departments of internal medicine.Policy Change and the National Essential Medicines List Development Process in Brazil between 2000 and 2014: Has the Essential Medicine Concept been Abandoned?

P2860

Q24187490-EE4C3FE8-E0A3-46D7-9728-23FCC8C63545 Q28072203-E0AC3AD9-346E-41BA-96D0-A73BF195EF90 Q28079380-3C790489-04EF-4A4F-B6A5-741CF6EB4249 Q28538501-834FD644-D643-4BA7-811D-06D797C1C737 Q30002316-82A1FB9D-00B5-4E24-B33F-F6A1F891FECA Q30002404-DEAC1699-60C0-45A9-8318-73D163E8D787 Q30401151-4D7A6F76-3A57-4E00-9369-BA1F9CD7B4BA Q31154098-6D5ACEFF-2548-486C-868D-3ADFE1B589CF Q33837648-BF655282-28E2-45E7-91C0-B41D6E8D2D34 Q34190968-34328906-6676-483C-A6FF-B756F2BEE15A Q34657198-289BF5C9-D182-4F4A-809C-BD4060430CF7 Q34938911-52437187-48C2-4177-B347-4A5609891A61 Q35041890-CDC4C36F-473A-446D-BF18-420D283FAF13 Q35047280-7288CC3B-F995-49A5-BDB4-5CD563F72C84 Q35659813-1741ED99-A219-4120-B946-36A6901E36A3 Q35935867-9A51AF5A-983E-4B18-8773-259BD0E6A3DE Q36015027-4E2ED962-036F-425F-A3A5-B21A5A359B5E Q36651515-7542EE82-F6F4-4DEB-BF26-2622A986FF93 Q36785642-3683BC60-E764-4575-A989-508E97B98AA3 Q37598383-F9DBFB85-1E8B-4E91-AA04-2279D727EBBD Q38098476-2AFC5556-4737-4486-AF2D-88959FA6AB40 Q38479788-1AC945D5-D414-4CA1-9561-8320CF6215D6 Q38682611-4F9FBE45-BFD8-426A-B09F-3EEEA61D328D Q38727828-E7373B90-F5B5-48ED-B947-207CD488A2E8 Q38824529-7DCD02B2-51C8-4BF3-BF22-5BFEC835467B Q38906003-7C497CAE-0B04-4309-9C0B-9562FF27395F Q39028094-9B83D60B-87D0-4DF2-9E2B-47C0614682B0 Q39076807-1A129461-10BE-420F-BBB6-5B80C64F9D5D Q40736061-EA0C9998-738A-432E-8B10-1ECCA9603BA2 Q42289325-C843DE8A-C3A0-4D22-8174-3AFA463E1529 Q42372433-CC231ECE-DBD9-4B8D-B80D-622FDB9A52F9 Q43358640-47AEFDA2-9CC5-4077-97FF-1C06ABB09BDD Q43645834-DB56E45A-E447-4BC0-8A5B-78D6AE8E88B7 Q43763549-430D73FF-5F94-4143-A667-69F8C5AAF729 Q44242526-9A92700E-C8E9-4266-BDC5-1C9CAE10AA88 Q45158316-5B0D2ADC-F8CA-4249-8872-F8A737207950 Q45832444-F92576DA-EED9-4AB5-B8CF-517552AEAFDD Q46096064-13324F24-1899-419D-9293-13774B9305C3 Q47927135-B068F616-0D61-41F1-B8EF-F8167B494268 Q50104677-B12ABF37-8997-45DD-AC2D-B2413194551A

P2860

Adverse drug reactions in Germany: direct costs of internal medicine hospitalizations.

http://www.wikidata.org/entity/Q45093086

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh-hant

name

Adverse drug reactions in Germany: direct costs of internal medicine hospitalizations.

@en

Adverse drug reactions in Germany: direct costs of internal medicine hospitalizations.

@nl

type

label

Adverse drug reactions in Germany: direct costs of internal medicine hospitalizations.

@en

Adverse drug reactions in Germany: direct costs of internal medicine hospitalizations.

@nl

prefLabel

Adverse drug reactions in Germany: direct costs of internal medicine hospitalizations.

@en

Adverse drug reactions in Germany: direct costs of internal medicine hospitalizations.

@nl

P1433

Q45093086-F7FB138E-5380-4B82-B1E6-448BBEFAA674

P1476

Q45093086-F399E0D9-8D3B-4B7F-B30A-9C339B3B3CB4

P2093

Q45093086-08AA6E9E-BEE3-4215-A735-5CF31E3FADAA

Q45093086-472371FD-24A1-4E78-A965-608CFA33ED67

Q45093086-74284669-89B9-441E-8222-17BEE3B4D2C0

Q45093086-89DE9D9E-A7B1-4F20-9C15-9FD6669F3357

Q45093086-B334C04E-F897-49D3-9EDC-484AD3DAD70A

Q45093086-CB05EEEF-066A-461D-B2D0-531023017522

Q45093086-E6223288-C205-4E0B-AE49-7792C58F43A1

Q45093086-E6582EBB-5D93-4CDB-85C8-D65CEC929A13

Q45093086-F75C1982-850C-4947-B227-FC095FFB93C9

Q45093086-F7677F03-C87A-4C41-AB0D-62E55E3A30B6

P2860

Q45093086-0E3487D5-F813-4D1F-BCB1-3D48F152F903

Q45093086-20B346F6-C87B-497F-B207-7AB159E20BE5

Q45093086-4764443E-0644-4B43-B7A8-4AD62673242C

Q45093086-5A485879-877C-48AE-8711-A5118BAAB7AD

Q45093086-5BA5E19E-9363-4EF7-8341-41D300DC4F5A

Q45093086-667F9F59-A678-4DF2-92D9-958B3015B89E

Q45093086-8393442C-7E12-44E7-A235-61C1CB4EEA03

Q45093086-8A7F4A06-AC00-4571-B735-EAB13B83AB5A

Q45093086-A37373CC-FE5D-4084-B5D9-1462F43F6480

Q45093086-A603567C-92AE-4DF5-950C-4257213C2C1A

P304

Q45093086-91D1EFB7-6FFB-4AFC-814C-0125C6C6ACBB

P31

Q45093086-A193D80A-9D6B-4AE5-8B63-B07EF2CBD5B2

P356

Q45093086-15964E3F-BB4B-4FD9-9610-2905477DF19C

P433

Q45093086-491A1B9A-BE5A-4356-8F1E-AC47ADCE2400

P478

Q45093086-D2CC6C34-3C67-49EF-B897-9A10F053FBCD

P577

Q45093086-CAB5F1A9-701C-480B-B75F-C2CD6750896C

P698

Q45093086-F9BD3B19-93FB-454B-B3D8-446510F6D6FC

P921

Q45093086-47d3cd42-227f-4a60-b5d3-0646cb0e35d0

Q45093086-9012C297-F3FE-49A1-A1D7-B6774161F719

Q45093086-CDCCA93A-1BE4-4F86-9105-082437B7A947

P356

P1433

Pharmacoepidemiology and Drug Safety

P1476

Adverse drug reactions in Germany: direct costs of internal medicine hospitalizations.

@en

P2093

Dominik Rottenkolber

http://www.w3.org/2001/XMLSchema#string

Joerg Hasford

http://www.w3.org/2001/XMLSchema#string

Karen Saljé

http://www.w3.org/2001/XMLSchema#string

Katrin Farker

http://www.w3.org/2001/XMLSchema#string

Marietta Rottenkolber

http://www.w3.org/2001/XMLSchema#string

Marion Hippius

http://www.w3.org/2001/XMLSchema#string

Net of Regional Pharmacovigilance Centers

http://www.w3.org/2001/XMLSchema#string

Petra A Thuermann

http://www.w3.org/2001/XMLSchema#string

Silke Mueller

http://www.w3.org/2001/XMLSchema#string

Sven Schmiedl

http://www.w3.org/2001/XMLSchema#string

P2860

Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients

Hospital admissions associated with adverse drug reactions: a systematic review of prospective observational studies.

Analysis of uncertainty in health care cost-effectiveness studies: an introduction to statistical issues and methods.

The cost of adverse drug reactions.

Assessing the economic impact of adverse drug effects.

Frequency and cost of serious adverse drug reactions in a department of general medicine.

Drug-related emergency department visits in an elderly veteran population.

Pharmacovigilance: methods, recent developments and future perspectives.

Admissions caused by adverse drug events to internal medicine and emergency departments in hospitals: a longitudinal population-based study.

Adverse drug reaction-related hospitalisations: a nationwide study in The Netherlands.

P304

626-634

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PDS.2118

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P577

2011-03-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21384463

http://www.w3.org/2001/XMLSchema#string

P921

internal medicine

hospitalization